At the post-marketing phase when drugs are used by large populations and for long periods, unexpected adverse events may occur altering the risk-benefit relation of drugs, sometimes requiring a regulatory action. These events at the post-marketing phase require a significant increase in health care since they result in unnecessary damage, often fatal, to patients. Therefore, the early discovery of adverse events in the post-marketing phase is a primary goal of the health system, in particular for pharmacovigilance systems.
INTRODUCTION
At the post-marketing phase when drugs are used by large populations and for long periods, adverse events (AE) may occur, altering the risk-benefit relation of drugs, sometimes requiring a regulatory action. Adverse events are health problems that may arise on users or patients during treatment with a drug. They could be caused by medication errors, low quality drugs, adverse drug reaction (ADR), medical interactions and poisoning (Mendes, 2008) .
ADR is any unintentional, harmful or undesirable drug response that occurs at regular doses given to a patient for prophylaxis, diagnosis, disease therapy or changes of physiological functions.
Despite the amount of research, tests and considerable time for a drug to reach its marketing stage, sometimes some adverse drug effects are not identified. The number of patients in phases I to III is limited, and its selection and treatment often differs from the methods used in clinical practice (Venulet and Ham, 1996) . For that, the earlier discovery of AEs in the post-marketing phase it is a primary goal of health's systems, mainly for the pharmacovigilance.
Computational methods commonly referred as "signal detection" or "tracking" algorithms allow drug safety evaluators to analyze a large amount of data to find signs of potential AE risks. These methods have been shown to have extreme significance in pharmacovigilance. For example, the Food and Drug Administration (FDA) routinely traces signals to generate statistics reports associations for all millions of drug combinations and events in their adverse event communication system. Nevertheless, these signs alone are not sufficient to confirm a causal relation, but can be considered as first warnings that require more evaluation by experts to establish causality. This new evaluation typically consists of a complex process in which the evaluators analyze drug safety information, such as time relations, published case reports in the literature, biological and clinical plausibility, data from clinical trials and epidemiological studies in multiple related health databases.
Several studies have shown that search logs (Ginsberg 2009; Denguetrends 2014; Flutrends 2014) and social networks (Signorini 2011; Lampos and Cristianini 2012) can be very useful for epidemiological surveillance networks. The main objective of this paper is to prove that Twitter can be used to find new "adverse drug event" associations. In order to do accomplish the objective we will build an automated system that will gather and process tweets to find these associations.
This paper is organized as following. describes the methods used to extract and process Twitter data. Section 3 describes the storage of the large amount of data. Section 4 shows the filtering of previous data to determine adverse events and/or drugs and evaluate tweets. Section 5 explains the disproportionality analysis used to find relevance from filtered data. Section 6 deals with an overview of the preliminary results. Section 7 concludes with future directions of this work. We will initially focus on neglected disease drugs like malaria and dengue, but we also will perform some research with AIDS. The system pipeline can be viewed in Figure 1 . 
TWITTER PROCESSOR
Twitter (Twitter, 2014 ) is a social network and microblogging service made up of 140-character messages called tweets, which are our targeted data. In this phase, data will be processed to facilitate the drug and adverse event associated to it. This stage has an initial step that consists of collecting tweets to process them afterwards. The data is in text format and should go through a process that extracts natural medicines, diseases and symptoms information to be mapped to Concept Unique Identifiers (CUIs) defined by the UMLS (Bodenreider, 2004) and other medical language patterns aiming standardization. In this phase the cTAKES (cTAKES, 2014) tool will be used.
Collecting Tweets
To collect tweets we studied the Twitter REST API (Twitter REST API, 2014) and Twitter Streaming API (Twitter Streaming API, 2014) . REST stands for Representational State Transfer architecture proposed by (Fielding, 2000) and is a way to perform CRUD operations (create, read, update or delete) on the server using simple HTTP calls. A REST Application Programming Interface (REST API) is a type of web server that enables a client, either user-operated or automated, to access resources that model a system's data and functions (Masse, 2011) . Both APIs need a Twitter's account for using and present some limitations. Therefore, we have searched other ways to get tweets with the four Twitter certified data resellers: (Topsy, 2014; Gnip, 2014; Datasift, 2014; Dataminr, 2014) . They all have access to Twitter's firehose (complete public data), and most of them have REST APIs to access these data. To get data from any reseller, a license is needed. Some give a temporary free license for research, but others only provide the data by means of the payment for the service.
We have made programs using both Twitter's API with the twitter rubygem (Twitter Rubygem, 2014) and some programs using the resellers API.
Twitter REST API
The REST API uses GET and POST methods to give access to many Twitter's resources like timelines, tweets, searches, direct messages, favorites, users, geolocation, followers, trends and others. However, it has several limitations such as:
 450 requests / 15 minutes  Returns only recent tweets (about 1 week) To use the API an API Key is needed and can be acquired freely.
A Ruby program was made to use this API. As the input, the searched query is used, and the list of tweets related to it is given as the output, which can be a file with one tweet per line or directly stored in a database.
Twitter Streaming API
This API allows access to continuous data stream from some resources. Hence, we keep a permanent connection with Twitter to gather new tweets that were related to some queries.
A Ruby program was also made to use this API. It receives as input the searched queries and as output, it stores news tweets in the database. Gathering these resources we intent to create a standard database for searching adverse events.
We are currently collecting tweets with neglected diseases.
Topsy
Topsy is a Twitter data reseller that claims to have all the tweets since 2006 and was bought by Apple in 2013. It also has an API with fewer resources than the official Twitter, being less limited than Twitter. To use the Topsy API, an API Key is also needed and with it, it is possible to search old tweets.
GNIP
GNIP is another Twitter data reseller. It also has data from others social networks as Tumblr, WordPress, Foursquare, Disqus, IntenseDebate, StockTwits, and GetGlue. It was recently bought by Twitter itself.
Others Data Resellers
DataSift has data from many social networks, and it has a very well documented API for developers, but it has not a free license for research. It also offers a seven days free trial period, being paid after it.
Dataminr focus in areas of Finance, News and the Public Sector, and it has not a free license. For that, we did not make a deep study of its resources.
Processing
After collecting the tweets, we will run them through natural language processor (NLP). Wu (2012) compared some tools for this task: Medlee (Friedman, 1994), cTAKES and MetaMap (Aronson, 2001) . One of the best-known NLP in the medical field is the Medlee. However, it is neither free anymore nor open source, so we chose cTAKES, an Apache NLP for extraction of medical data, using some sources that we will use to create our benchmark.
We also use the MedlinePlus Connect Web Service (MedlinePlus, 2014) and the RxNorm RESTful API (RxNorm API, 2014) to get drug adverse effects and name spelling suggestions. For better use of cTAKES with UMLs, a UML user ID and password are needed, which can be acquired freely at the U.S. National Library of Medicine / National Institutes of Health (NIH) (NLM, 2014) . Because cTAKES's language is java, we made a java program for better and faster integration with it. The program has as input, the query (a drug or disease) used in the previous session. It search the database for all tweets related to that query to process each one with cTAKES.
cTAKES

MedlinePlus Connect Web Service
MedlinePlus Connect is a free service of the NLM/NIH and the Department of Health and Human Services (HHS). It provides up-to-date health information resources.
MedlinePlus Connect Web Service supports the International Classification of Diseases (ICD), the National Drug Code Directory (NDC), the normalized naming system for generic and branded drugs (RxNorm), the Systematized Nomenclature of Medicine, Clinical Terms (SNOMED CT) and others codes.
We used it to get drug adverse effects. For that, we made a ruby program that uses as input an RXCUI or NDC from a drug. The output consists in the adverse effects of this drug classified as normal or serious.
For example, the input '49349056102' (NDC from mesalamine) returns: back pain, nausea, vomiting, heartburn, burping, constipation, gas, dry mouth, itching, dizziness, sweating, acne, slight hair loss, decreased appetite and others adverse effects associated to that drug.
RxNorm RESTful API
The RxNorm RESTful API is a webservice developed at the NLM for accessing RxNorm data. We use it to get the RxCUI from a drug name and to get drug spelling suggestions to search in tweets. This API is used in a ruby program integrated with the MedlinePlus Connect.
DATABASE
As working database, we chose the noSQLDB due to the large amount of data to be processed. The specific noSQLDB we use is MongoDB because we are using only one server. Figure 2 shows how we store tweets in MongoDB Documents. Query { {"text":"malaria", "tweets_documents":[ {"name":"Malaria1","start":"01/01/2010", "end":"31/12/2010"}, {"name":"Malaria2","start":"01/01/2011", "end":"31/12/2011"},.
.. ]}, {"text":"dengue", "tweets_documents":[ {"name":"Dengue1","start":"01/01/2010", "end":"31/12/2010"}, {"name":"Dengue2","start":"01/01/2011", "end":"31/12/2011"},.
.. ]} }
Malaria1
{ "tweets":[ {"_id":"12345","text":"Tweet text1", "created_at":"01/02/2010", "author":"author1"}, {"_id":"6789","text":"Tweet text2", "created_at":"01/03/2010", "author":"author2"}, {"_id":"99999","text":"Tweet text3", "created_at":"01/03/2010", "author":"author3"}, ] }
Malaria2
... The query document contains all the queries and a link to the tweet's documents that belong to it. Each tweet's document has at most 100,000 tweets.
MongoDB also has documents for diseases and its adverse effects. These documents were created using the MedlinePlus Connect Web Service.
FILTERING
Each run of the system will be directed to one or more drugs and/or particular adverse events previously defined. In this step data from the previous one will be filtered to leave only drug and/or adverse events needed to the current execution.
DISPROPORTIONALITY ANALYSIS
Disproportionality analysis methods for drug safety surveillance are the primary class of analytic methods used to analyze data from spontaneous reporting system (SRS). SRSs receive reports that comprise of one or more drugs, one or more adverse events (AEs) (Zorych, 2013) . In this paper, we are considering tweets as SRS's reports. Some of the most used disproportionality analysis methods are the multi-item gamma-Poisson shrinker, MGPS, (DuMouchel 1999; DuMouchel and Pregibon 2001; Fram 2003) , proportional reporting ratios, PRR, (Evans, 2001) , reporting odd ratios, ROR, (Rothman, 2004) , and Bayesian confidence propagation neural network, BCPNN, (Bate 1998; Norén 2006) .
The basic task of a disproportionality method is to rank order the tables in order of "interestingness". These methods search within SRS databases for "interesting" associations and focus on low dimensional projections of the data, specifically 2-dimensional contingency tables. Different disproportionality methods focus on different statistical measures of association as their measure of "interestingness". MGPS focuses on the "reporting ratio" (RR).
All these measures will serve to classify the drug-adverse event peers previously identified. We are currently using the Reporting Ratio (RR), PRR, ROR and the information component (IC) used by BCPNN but we intend to use also the MGPS with a larger amount of tweets. Table 1 shows a typical table, each number in the table represents the amount of tweets. All tweets have the disease "malaria". Table 1 shows all possible combinations with the drug "chloroquine" and the adverse effect "itching". Table 2 shows the formulae for the measures of association we used and the values related to the example above. Letters 'a', 'b', 'c', 'd', 't', 'm' and 'n' are values from Table 1 . The 'n' value shows us the amount of tweets containing that adverse drug event. The higher the values, the higher the probability the drug to cause the AE. Also, if the drug and the AE are stochastically independent, the measures will have a null value. We currently only did these analysis counting the words in tweets but further analysis will be made using cTAKES. The system performs this analysis for all drugs/ adverse effects in the database for the input query.
PRELIMINARY RESULTS
First, we queried Twitter to see the amount of tweets related to some neglected diseases since its creation in 2006, but until 2008 there were few tweets per month (less than 200), so we decided to show only tweets from 2008/Jan to 2014/Jun.
We searched for tuberculosis (196790 tweets), Chagas disease (19999 tweets), leishmania (53338 tweets), dengue (3587284 tweets) and malaria (2161169 tweets). As it can be seen in Figure 3 , dengue and malaria are the ones with most tweets. The y-axis represents the amount of tweets in 10,000 scale and the x-axis the month since 2008/Jan.
Since there are no drugs for dengue, we have chosen malaria for further research. However, because dengue is one of Brazil's principal diseases we studied its tweets a little more and constructed a tweet/per month graph as showed in Figure 4 . Figure 4 show that the peaks of tweets were in May, which is the month when we recorded higher indices of dengue. This event shows that tweets could be used for dengue's research. After this, we queried tweets related to some of its drugs: mefloquine, lariam, chloroquine, doxycycline and primaquine. We also queried AIDS/HIV and its drugs: efavirenz, abacavir, stavudine, delavirdine, didanosine, etravirine, emtricitabine, zidovudine, nevirapine, lamivudine, rilpivirine. Table 3 bellow shows some reporting ratio values we have found at the disproportionality analysis. 
DISCUSSION
This system is still under construction, and it is one of multiple pipelines, each one with different data sources that will then be combined to obtain new AE and historical changes in already knew AE. We already found strong indication that tweets can be used as a source for pharmacovigilance and one of the possible uses is for dengue studies because dengue's tweets peak happened in the same month as the disease did (Figure 4) . In our study, we found that malaria and dengue where the most tweeted diseases. Further research will be made with others neglected diseases.
So far, obtained results on disproportionality indicate that Twitter can be used to find AE, as it was shown in Table 3 . Hence, we can proceed our research on Twitter to finding new drug AEs.
Since Twitter reliability for finding new drug AEs is not known, one of our tasks is to find already known adverse drug events in tweets to see that reliability. 
